Search research articles
Contact Us
Filters
Showing results (1-10 of 12) with videos related to
Page
of 2
Sort By:
Geroscience
|
July 24, 2020
Brain angiotensin II and angiotensin IV receptors as potential Alzheimer's disease therapeutic targets
Jessika Royea, Edith Hamel
Methods in Molecular Biology (Clifton, N.J.)
|
July 1, 2022
Examining Mitochondrial Morphology in Mouse Brains
Jessika Royea, Mireille Khacho
Neurobiology of Disease
|
November 1, 2019
Memory and cerebrovascular deficits recovered following angiotensin IV intervention in a mouse model of Alzheimer's disease
Jessika Royea, Pauline Martinot, Edith Hamel
Cell Death & Disease
|
April 10, 2022
Simvastatin rescues memory and granule cell maturation through the Wnt/β-catenin signaling pathway in a mouse model of Alzheimer's disease
Xin-Kang Tong, Jessika Royea, Edith Hamel
Cellular and Molecular Neurobiology
|
March 20, 2016
Neurovascular and Cognitive failure in Alzheimer's Disease: Benefits of Cardiovascular Therapy
Edith Hamel, Jessika Royea, Brice Ongali, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
May 7, 2017
Angiotensin IV Receptors Mediate the Cognitive and Cerebrovascular Benefits of Losartan in a Mouse Model of Alzheimer's Disease
Jessika Royea, Luqing Zhang, Xin-Kang Tong, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
September 27, 2019
Comparative benefits of simvastatin and exercise in a mouse model of vascular cognitive impairment and dementia
Lianne J Trigiani, Jessika Royea, Xin-Kang Tong, et al.
Methodsx
|
March 5, 2026
Texture preference task: a rapid and training-independent behavioural assay to evaluate somatosensory perception in freely moving mice
Jessika Royea, Ismaël Djerourou, Behiye Sanliturk, et al.
Hypertension (Dallas, Tex. : 1979)
|
October 26, 2018
Pleiotropic Benefits of the Angiotensin Receptor Blocker Candesartan in a Mouse Model of Alzheimer Disease
Lianne J Trigiani, Jessika Royea, María Lacalle-Aurioles, et al.
Hypertension (Dallas, Tex. : 1979)
|
May 5, 2020
AT2R's (Angiotensin II Type 2 Receptor's) Role in Cognitive and Cerebrovascular Deficits in a Mouse Model of Alzheimer Disease
Jessika Royea, Maria Lacalle-Aurioles, Lianne J Trigiani, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 12) with videos related to
Sort By:
Page
of 2
Geroscience
|
July 24, 2020
Brain angiotensin II and angiotensin IV receptors as potential Alzheimer's disease therapeutic targets
Jessika Royea, Edith Hamel
Methods in Molecular Biology (Clifton, N.J.)
|
July 1, 2022
Examining Mitochondrial Morphology in Mouse Brains
Jessika Royea, Mireille Khacho
Neurobiology of Disease
|
November 1, 2019
Memory and cerebrovascular deficits recovered following angiotensin IV intervention in a mouse model of Alzheimer's disease
Jessika Royea, Pauline Martinot, Edith Hamel
Cell Death & Disease
|
April 10, 2022
Simvastatin rescues memory and granule cell maturation through the Wnt/β-catenin signaling pathway in a mouse model of Alzheimer's disease
Xin-Kang Tong, Jessika Royea, Edith Hamel
Cellular and Molecular Neurobiology
|
March 20, 2016
Neurovascular and Cognitive failure in Alzheimer's Disease: Benefits of Cardiovascular Therapy
Edith Hamel, Jessika Royea, Brice Ongali, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
May 7, 2017
Angiotensin IV Receptors Mediate the Cognitive and Cerebrovascular Benefits of Losartan in a Mouse Model of Alzheimer's Disease
Jessika Royea, Luqing Zhang, Xin-Kang Tong, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
September 27, 2019
Comparative benefits of simvastatin and exercise in a mouse model of vascular cognitive impairment and dementia
Lianne J Trigiani, Jessika Royea, Xin-Kang Tong, et al.
Methodsx
|
March 5, 2026
Texture preference task: a rapid and training-independent behavioural assay to evaluate somatosensory perception in freely moving mice
Jessika Royea, Ismaël Djerourou, Behiye Sanliturk, et al.
Hypertension (Dallas, Tex. : 1979)
|
October 26, 2018
Pleiotropic Benefits of the Angiotensin Receptor Blocker Candesartan in a Mouse Model of Alzheimer Disease
Lianne J Trigiani, Jessika Royea, María Lacalle-Aurioles, et al.
Hypertension (Dallas, Tex. : 1979)
|
May 5, 2020
AT2R's (Angiotensin II Type 2 Receptor's) Role in Cognitive and Cerebrovascular Deficits in a Mouse Model of Alzheimer Disease
Jessika Royea, Maria Lacalle-Aurioles, Lianne J Trigiani, et al.
Page
of 2